DUBLIN--(BUSINESS WIRE)--The "Part B Payment Model Indexing Commercial Discounts Proposed By Genentech" newsletter has been added to ResearchAndMarkets.com's offering.
Genentech, Inc. has designed a Medicare Market-based Pricing Model that replaces the average sales price (ASP) method currently used with a new approach, while retaining the current buy-and-bill system.
Learn more about this proposed model, which also provides a means for CMS to pass savings on to patients at the point of sale. Find out why Genentech believes the model would accelerate spur private-market negotiations and how it may affect overall ASP and Medicare reimbursement.
For more information about this newsletter visit https://www.researchandmarkets.com/r/hvivc8